Skip to content

Postoperative Balloninflation After Evacuation of cSDH

Balloninflation After Evacuation of Chronical Subdural Haematoma for Reduction of Hematoma Recurrrence: Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04060186
Acronym
BANISH
Enrollment
200
Registered
2019-08-19
Start date
2020-01-01
Completion date
2022-02-28
Last updated
2019-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Subdural Hematoma

Keywords

Recurrence rate of cSDH, Outcome

Brief summary

In this prospective, randomized, multicenter trial shall patients with chronic subdural hematoma (cSDH) recruited, who were surgically treated. Initially, we would divide the patients randomized into two groups: Patients with supervised blow-maneuver and without. After surgical treatment of cSDH with insertion of a subdural drain, one group would perform a supervised blow maneuver (Valsalva maneuver) every hour for five minutes from 10:00 to 20:00. In the other group, the standard care would be performed. The subdural drain would be explanted 2days after operation and a postoperative CT scan would routinely be performed. After hospital discharge, the patient would be rechecked in an ambulant setting and would receive CT scan as clinical standard. Recurrence of hematoma is defined as recurrent hematoma which should be reoperated. After 3 and 6 months we would evaluate the outcome of patients.

Interventions

PROCEDUREBalloninflation

Patient will inflate into a ballon made by a handglove 2-3times/h from 8:00-20:00 after evacuation of chronic subdural hematoma.

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* age over 18 years * surgically treated cSDH * patients with an operatively implanted subdural drainage

Exclusion criteria

* age under 18 years * Admission in critical clinical state, e.g. already to light unresponsive pupils for about 2 hours * conservative treatment of cSDH * patients without an operatively implanted subdural drainage * patient cannot be consented * participation in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Recurrence Rate3 MonthsReoperation of chronic subdural hematoma

Secondary

MeasureTime frameDescription
Neurological Functional Outcome6 MonthsModified Rankin Scale (0-6) 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead. mRS0-3: favorable Outcome mRS: 4-6: unfavorable Outcome

Countries

Germany

Contacts

Primary ContactSae-Yeon Won, MD
sae-yeon.won@kgu.de06963014291
Backup ContactAnne Sicking
anne.sicking@kgu.de06963014291

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026